Total Return chart PharmaEssentia Corporation

Stocks

End-of-day quote Taiwan S.E. 11/09/2026			5-day change	1st Jan Change
1,280.00 ^TWD	-3.03%		-2.29%	+202.10%

09-02	PharmaEssentia Receives FDA Approval For Ropeginterferon Alfa-2b-njft For Essential Thrombocythemia	CI
08-31	PharmaEssentia Gets US FDA's Approval for Essential Thrombocythemia Treament Drug; Shares Sink 10%	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

08/07/2026	Annual 1.490152 TWD
10/08/2025	Annual 1.098385 TWD